# Axcelis Technologies Inc: Form 10-Q for the period ended Mar 31, 2018

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2018-05-04
- Accepted by EDGAR: May 4, 2018, 13:38 ET
- Period: 2018-03-31
- Accession: 0001558370-18-003997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000155837018003997/acls-20180331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000155837018003997/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-01-01 to 2018-03-31 | $122.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $75.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $47.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $12.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | $18.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-01-01 to 2018-03-31 | $1.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $3.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $13.9m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 34,123,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | $8.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $723.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-03-31 | $141.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $361.6m | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $505.1m | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $77.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-03-31 | $133.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-03-31 | $371.5m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,526 characters.

*Certain statements in "Management's Discussion and Analysis of Financial Condition and Results of Operations" are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth under "Liquidity and Capital Resources" below and under “Risk Factors” in Part II, Item 1A to our annual report on Form 10-K for the year ended December 31, 2017, which discussion is incorporated herein by reference. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.*

### Overview

Axcelis is a producer of ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades and maintenance services to the semiconductor industry. Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our ten largest customers accounted for 87.6% of total revenue for the three months ended March 31, 2018.

Our product development and manufacturing activities occur primarily in the United States. Our equipment and service products are highly technical and are sold primarily through a direct sales force in the United States, Europe and Asia. In the first quarter of 2018, we signed an agreement with Screen Semiconductor Solutions Co., Ltd., a Japanese semiconductor equipment company, to establish a sales and service network to distribute Purion products to customers in Japan.

In the first quarter of 2018, higher revenues were the result of customers’ increasing selection of Purion ion implanters due to strong spending by customers serving the memory and mature process technology segments.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations included herein and in our Annual Report on Form 10-K for the year ended December 31, 2017 are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2017.

### Results of Operations

The following table sets forth our results of operations as a percentage of total revenue:

| Revenue: | Three months ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Product | 95.0% | 94.3% |
| Services | 5.0 | 5.7 |
| Total revenue | 100.0 | 100.0 |
| Cost of revenue: |  |  |
| Product | 56.0 | 53.9 |
| Services | 5.4 | 6.1 |
| Total cost of revenue | 61.4 | 60.0 |
| Gross profit | 38.6 | 40.0 |
| Operating expenses: |  |  |
| Research and development | 10.0 | 11.4 |
| Sales and marketing | 6.9 | 8.1 |
| General and administrative | 6.6 | 8.1 |
| Total operating expenses | 23.5 | 27.6 |
| Income from operations | 15.1 | 12.4 |
| Other (expense) income: |  |  |
| Interest income | 0.3 | 0.1 |
| Interest expense | (1.1) | (1.3) |
| Other, net | (0.1) | (0.2) |
| Total other expense | (0.9) | (1.4) |
| Income before income taxes | 14.2 | 11.0 |
| Income tax provision | 2.9 | — |
| Net income | 11.3% | 11.0% |

### Revenue

The following table sets forth our revenue:

*(dollars in thousands)*

| Revenue: | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $116,022 | $81,978 | $34,044 | 41.5% |
| Percentage of revenue | 95.0% | 94.3% |  |  |
| Services | 6,163 | 4,915 | 1,248 | 25.4% |
| Percentage of revenue | 5.0% | 5.7% |  |  |
| Total revenue | $122,185 | $86,893 | $35,292 | 40.6% |

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

#### Product

Product revenue, which includes system sales, sales of spare parts, product upgrades and used systems was $116.0 million, or 95.0% of revenue during the three months ended March 31, 2018, compared with $82.0 million, or 94.3% of revenue for the three months ended March 31, 2017. The $34.0 million increase in product revenue for the three month period ending March 31, 2018, in comparison to the same period in 2017, was primarily driven by an increase in the number of Purion systems sold.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at March 31, 2018 and December 31, 2017 was $18.5 million and $18.1 million, respectively. The increase in deferred revenue is primarily due to the increase in the number of systems sold in the quarter.

#### Services

Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $6.2 million, or 5.0% of revenue for the three months ended March 31, 2018, compared with $4.9 million, or 5.7% of revenue for the three months ended March 31, 2017. Although services revenue typically increases with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.

### Revenue Categories used by Management

As an alternative to the line item revenue categories discussed above, management also uses revenue categorizations which divide revenue into new systems sales and “aftermarket,” meaning sales of spare parts, product upgrades and used systems, combined with the sale of maintenance labor and service contracts and services hours.

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

#### New Systems

Included in total revenue of $122.2 million during the three months ended March 31, 2018 is revenue from sales of new systems of $85.5 million, or 70.0% of total revenue, compared with $55.2 million, or 63.6%, of total revenue for the three months ended March 31, 2017. The increase was due to higher sales of our Purion systems sold in the recent quarter.

#### Aftermarket

Included in total revenue of $122.2 million during the three months ended March 31, 2018 is revenue from our aftermarket business of $36.7 million, compared to $31.6 million for the three months ended March 31, 2017. Aftermarket revenue fluctuates from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service. Aftermarket revenue can also fluctuate from period to period based on the demand for system upgrades or used tools.

### Gross Profit / Gross Margin

The following table sets forth our gross profit / gross margin:

*(dollars in thousands)*

| Gross Profit: | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $47,648 | $35,181 | $12,467 | 35.4% |
| Product gross margin | 41.1% | 42.9% |  |  |
| Services | (492) | $(467) | (25) | 5.4% |
| Services gross margin | (8.0)% | (9.5)% |  |  |
| Total gross profit | $47,156 | $34,714 | $12,442 | 35.8% |
| Gross margin | 38.6% | 40.0% |  |  |

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

#### Product

Gross margin from product revenue was 41.1% for the three months ended March 31, 2018, compared to 42.9% for the three months ended March 31, 2017. The decrease in gross margin of 1.8 percentage points resulted from a higher mix of Systems revenue and a lower mix of parts and upgrades revenue.

#### Services

Gross margin from services revenue was (8.0)% for the three months ended March 31, 2018, compared to (9.5)% for the three months ended March 31, 2017. The improvement in gross margin in the recent period is primarily attributable to reduced costs on service contracts.

### Operating Expenses

The following table sets forth our operating expenses:

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $12,233 | $9,895 | $2,338 | 23.6% |
| Percentage of revenue | 10.0% | 11.4% |  |  |
| Sales and marketing | 8,411 | 7,049 | 1,362 | 19.3% |
| Percentage of revenue | 6.9% | 8.1% |  |  |
| General and administrative | 8,010 | 7,057 | 953 | 13.5% |
| Percentage of revenue | 6.6% | 8.1% |  |  |
| Total operating expenses | $28,654 | $24,001 | $4,653 | 19.4% |
| Percentage of revenue | 23.5% | 27.6% |  |  |

Our operating expenses consist primarily of personnel costs, including salaries, commissions, expected incentive plan payouts, stock-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses.

Personnel costs are our largest expense, representing $17.9 million or 62.5% of our total operating expenses for the three month period ended March 31, 2018. Personnel costs were $14.6 million or 60.6%, of our total operating expenses for the three month period ended March 31, 2017. The higher personnel costs for the three months March 31, 2018 are primarily due to increased headcount to support growth.

### Research and Development

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $12,233 | $9,895 | 2,338 | 23.6% |
| Percentage of revenue | 10.0% | 11.4% |  |  |

Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems and introducing them at competitive prices on a timely basis. Accordingly, based on our strategic plan, we establish annual R&D budgets to fund programs that we expect will provide customers with competitive performance advantages.

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

Research and development expense was $12.2 million during the three months ended March 31, 2018; a $2.3 million, or 23.6%, increase from $9.9 million during the three months ended March 31, 2017. The increase is primarily due to increased headcount to support the development of new Purion products.

### Sales and Marketing

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Sales and marketing | $8,411 | $7,049 | $1,362 | 19.3% |
| Percentage of revenue | 6.9% | 8.1% |  |  |

Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

Sales and marketing expense was $8.4 million during the three months ended March 31, 2018; an increase of $1.4 million, or 19.3%, compared with $7.0 million during the three months ended March 31, 2017. The increase is primarily due to increased headcount to support our growing business.

### General and Administrative

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| General and administrative | $8,010 | $7,057 | 953 | 13.5% |
| Percentage of revenue | 6.6% | 8.1% |  |  |

Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.

#### Three months ended March 31, 2018 Compared with Three months ended March 31, 2017

General and administrative expense was $8.0 million during the three months ended March 31, 2018; an increase of $1.0 million, or 13.5%, compared to $7.1 million during the three months ended March 31, 2017. The increase is primarily due to increased headcount to support our growing business.

### Other (Expense) Income

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Other (expense) income | $(1,029) | $(1,196) | $167 | 14.0% |
| Percentage of revenue | (0.9)% | (1.4)% |  |  |

Other (expense) income consists primarily of interest relating to the lease obligation we incurred in connection with the 2015 sale of our headquarters facility (“sale leaseback)” and other financing obligations, foreign exchange gains and losses attributable to fluctuations of the U.S dollar against local currencies of certain of the countries in which we operate as well as interest earned on our invested cash balances. Other expense was $1.0 million for the three months ended March 31, 2018, compared with $1.2 million for the three months ended March 31, 2017.

The decrease in other expense for the three month period ended March 31, 2018 compared to the three month period ended March 31, 2017, was primarily due to interest earned on our invested cash.

During the three month periods ended March 31, 2018 and 2017, with the exception of operating lease agreements entered into by the Company, we had no significant off-balance-sheet risk such as exchange contracts, option contracts or other hedging arrangements.

### Income Tax Provision

*(dollars in thousands)*

|  | Three months ended March 31, 2018 | 2017 | Period-to-period change $% |  |  |
| --- | ---: | ---: | ---: | --- | --- |
| Income tax provision | $3,558 | $11 | $3,547 | N/M | \* |
| Percentage of revenue | 2.9% | —% |  |  |  |

\*Not Meaningful

During the three months ended March 31, 2018 and 2017, we recorded income tax provisions of $3.6 million and $11 thousand, respectively. The change in the income tax provision for the current quarter compared to the prior year was primarily due to the release of a significant portion of our valuation allowance for previously unrecognized net operating losses that offset any U.S. tax provision for the three months ended March 31, 2017. We have significant net operating loss carryforwards in the United States and certain European jurisdictions, and, as a result, we do not currently pay significant income taxes in those jurisdictions.

At December 31, 2017, the Company had $90.3 million of deferred tax assets worldwide relating to net operating loss carryforwards, tax credit carryforwards and other temporary differences, which are available to reduce income taxes in future years. Management considered the weight of all available evidence in determining whether a valuation allowance was required against its deferred tax assets at December 31, 2017. After consideration of both positive and negative evidence, management concluded in 2017 that it is more likely than not that a substantial portion of the Company’s deferred tax assets will be realized. The positive evidence considered was three year U.S. historical cumulative profitability, projected future taxable income and length of carry-forward periods of net operating losses and tax credits. The primary negative evidence considered is the volatile semiconductor industry in which the Company operates. The Company has continued to maintain a $7.1 million valuation allowance in the U.S. against certain tax credits and state net operating losses due to the uncertainty of their realization based on long-term Company forecasts and the expiration dates on these attributes.

### Liquidity and Capital Resources

The Company had $141.0 million in unrestricted cash and cash equivalents at March 31, 2018, in addition to $7.5 million in restricted cash, primarily comprised of the $5.9 million security deposit for the lease of our corporate headquarters. Management believes that maintaining a strong cash balance is necessary to provide funding for potential ramps in our business, which can require significant cash investment to meet sudden demand.

Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of sale of our products, and others relate to the uncertainties of global economies, including the availability of credit and the condition of the overall semiconductor equipment industry. Our established cost structure, other than cost of goods sold, does not vary significantly with changes in volume. We experience fluctuations in operating results and cash flows depending on these factors.

During the three months ended March 31, 2018, the Company generated $8.5 million of cash from operating activities. This was predominately driven by strong sales resulting in net income of $13.9 million. In comparison, during the three months ended March 31, 2017, the Company used $2.7 million of cash in operating activities.

Investing activities for the three months ended March 31, 2018 and 2017 resulted in cash outflows of $0.7 million and $1.1 million, respectively, used for capital expenditures.

Financing activities for the three months ended March 31, 2018 and 2017 provided net cash of $0.2 million and $2.2 million, respectively, primarily relating to the proceeds from the exercise of stock options.

We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash, cash equivalents and borrowing capacity will be sufficient to satisfy our anticipated cash requirements for the short and long-term. We currently have no credit facility but management believes we would be able to borrow on reasonable terms if needed.

### Commitments and Contingencies

Significant commitments and contingencies at March 31, 2018 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 14 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

## Market risk

As filed, 200 characters.

As of March 31, 2018, there have been no material changes to the quantitative information about market risk disclosed in Item 7A to our annual report on Form 10-K for the year ended December 31, 2017.

## Controls and procedures

As filed, 1,033 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the three months ended March 31, 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 170 characters.

As of March 31, 2018, there have been no material changes to the risk factors described in Item 1A to our annual report on Form 10-K for the year ended December 31, 2017.

Filed May 4, 2018.
Source: SEC EDGAR, the filing index for accession 0001558370-18-003997. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
